New device could speed up bleeding checks in Kids' heart surgery

NCT ID NCT07597278

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new device called the Quantra System to see how well it measures blood clotting in children undergoing heart surgery or with bleeding after surgery. The device gives quick results from a small blood sample. Researchers will compare its readings to those from standard clotting tests. The goal is to see if this device can help doctors manage bleeding more effectively in young patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Quantra System with QPlus Cartridge (diagnostic device)
What this could lead to
If successful, this device could help doctors quickly assess bleeding risk in children during heart surgery, leading to better and faster treatment decisions.
What could go wrong
This is an early-stage study focused on comparing the device to existing methods. It does not test whether using the device actually improves patient outcomes, so real-world benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD LOSS, SURGICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Healthcare of Atlanta

    Atlanta, Georgia, 30329, United States

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • UCLA Mattel Children's Hospital

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.